Pediatric poisoning from trimedoxime (TMB4) and atropine automatic injectors

Eran Kozer1, Amnon Mordel, Shmuael Bar Haim

  • 1Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. erank@asaf.health.gov.il

The Journal of Pediatrics
|January 13, 2005
PubMed

Insights

Unintentional pediatric injection of atropine and trimedoxime (TMB4) via automatic injectors rarely causes significant side effects, even with adult doses in children. Most side effects were mild and related to atropine.

Area of Science:

  • Pediatric Toxicology
  • Emergency Medicine
  • Pharmacology

Background:

  • Automatic injectors (AIs) containing atropine and trimedoxime (TMB4) are used for treating nerve agent exposure.
  • Accidental pediatric exposure to these AIs can occur, necessitating an understanding of potential adverse effects.

Purpose of the Study:

  • To investigate the clinical effects and safety profile of unintentional pediatric exposure to combined atropine and TMB4 from automatic injectors.

Main Methods:

  • Retrospective data collection from the Israel Poison Information Center and pediatric emergency departments.
  • Analysis of demographic data, AI type, injection details, and clinical manifestations in 142 pediatric patients.

Main Results:

  • Most patients received age-appropriate doses; however, 15.5% received higher doses.
  • Mild atropine-related side effects observed included dilated pupils, dry mucous membranes, and tachycardia.
  • Children receiving higher doses were more likely to be symptomatic (P = .029).
  • No significant side effects were attributed to TMB4, and no specific medical intervention was required.

Conclusions:

  • Unintentional pediatric exposure to atropine and TMB4 via AIs, even at adult doses, is generally safe.
  • The observed side effects are typically mild and transient, primarily linked to atropine.
Abstract

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...